In a setback, Singh brothers lose appeal in Rs 3,500-crore arbitral award

The brothers are currently in judicial custody following Supreme Court order in November last year that held them guilty of violating earlier court orders

Shivinder Mohan Singh, Malvinder Mohan Singh, Ranbaxy, Fortis, Religare
Former Ranbxy Laboratories promoters Shivinder Mohan Singh (top left) and Malvinder Singh chairman (front centre). Photo: Dalip Kumar
Sudipto Dey New Delhi
1 min read Last Updated : May 29 2020 | 4:31 AM IST
In a setback to the Singh brothers, Malvinder Mohan Singh and Shivinder Mohan Singh, Singapore Court of Appeal has dismissed the appeals filed by them against the judgment of the HC of Singapore, which had refused to set aside the arbitral award in favour of Daiichi Sankyo Company.
 
The brothers are in judicial custody following the Supreme Court order last year that held them guilty of violating earlier court orders that forbade them to sell their stake in Fortis Healthcare.
 
The brothers were given time till March 2020 for a plan to honour the Rs 3,500-crore arbitration order against them.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Singh brothersRanbaxySupreme Court

Next Story